Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
1999-03-17
2001-05-22
Rotman, Alan L. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S044000
Reexamination Certificate
active
06235906
ABSTRACT:
The present invention relates to a novel process for the preparation of codeinone and analogues thereof.
Codeinone is a key intermediate for the synthesis of many morphinoid compounds. It is therefore desirable for a simple, straightforward and cost effective process for its preparation.
In earlier works, codeinone was obtained from thebaine by treating it with dry HBr in CH
2
Cl
2
at −25°, followed by hydrolysis with water and dehydrobrominating with cold NaOH (Vesely, Z., Hodkova, J. and Trojanek J., Cesk. Farm. 1986, 35, 222-6). In another method, thebaine was converted to a mixture of codeinone and neopinone in aqueous HCO
2
H containing Hg(OAc)
2
(U.S. Pat. No. 4,277,604). However, thebaine is very expensive and does not occur naturally in a high yield; therefore the preparation of codeinone from thebaine is not an attractive method.
An alternative process for the preparation of codeinone is the direct oxidation of codeine using variety of reagents, such as silver carbonate (Rapoport, H. and Reist, N. H., J. Am. Chem. Soc. 1955, 77, 490-491) and Jones' reagent (Findlay, J. W. A., Butz, R. F. and Jones, E. C., Clin. Chem. 1981, 27, 1524-1535); however, these reagents only gave codeinone in poor yield. Only Oppenauer oxidation (U.S. Pat. No. 2,654,756) has given codeinone in reasonably good yield and high purity. All these methods have their drawbacks, however. Oxidation with silver carbonate is not preferred due to its cost and incomplete reaction, whereas in the case of Jones' oxidation and Oppenauer oxidation the isolation of the product is difficult and complex.
The direct oxidation of codeine with active manganese dioxide (Ninan, A. and Sainsbury, M., Tetrahedron, 1992, 48, 6709) and &ggr;-manganese dioxide (Highet, R. J. and Wildman, W. C., J. Am. Chem. Soc., 1955, 77, 4399) has also been reported. However, in both cases pure codeinone was obtained in only low yield due to the formation of 14&bgr;-hydroxycodeinone and low conversion.
The object of the present invention is to provide a simple process for the preparation of codeinone and analogues thereof, and which provides the desired product in high yield and purity. The present inventors have found that if oxidation of codeine or a salt thereof, for example the phosphate salt, is carried out at acidic pH, a high yield of codeinone is obtained which is not obtainable by any of the methods heretofore disclosed.
Accordingly, the present invention provides a novel process for the preparation of a compound of formula (I)
wherein R
1
is lower alkyl or a group
wherein R
4
is lower alkyl, lower alkyl substituted by halogen or phenyl, phenyl or substituted phenyl; and
R
2
is lower alkyl, allyl or lower alkyl substituted by cycloalkyl;
comprising the oxidation of a compound of formula (II),
or a salt thereof, wherein R
1
and R
2
are as hereinbefore defined; characterised in that the oxidation is carried out in an acidic environment.
Preferably, each of R
1
and R
2
may be the same or different and each is lower alkyl, for example C
1-6
alkyl, such as C
1-4
alkyl, for example methyl or ethyl and preferably ethyl.
When the compound of formula (II) is present as a salt, preferably the salt is the phosphate salt (H
3
PO
4
).
Suitably the oxidation is carried out at a pH of from 0.1<pH>7; preferably, the oxidation is carried out at a pH of from 0.8<pH>4.5; most preferably the oxidation is carried out at a pH of from 0.8 to 1.2.
The solvent may be any solvent suitable for use in such an oxidation reaction. Acetone was found to be the most suitable solvent for giving the desired product in high yield and high purity. Other solvents were also found to be particularly useful and were preferred in the order: acetone>THF>IPA>CH
3
CN>NMP. Preferably, the solvent is used as a 50:50 (v/v) solvent/water mixture.
The oxidation reagent is suitably manganese dioxide, such as activated manganese dioxide or &ggr;-manganese dioxide, preferably &ggr;-manganese dioxide. Suitably, the oxidation reagent is present in an amount of at least 3 equivalents or more with respect to the compound of formula (I).
The invention will now be further described by way of example only.
General Procedure for the Preparation of Codeinone from Codeine Phosphate or Codeine
A solution of codeine or codeine phosphate was dissolved in the appropriate solvent system and a specified volume of hydrochloric acid of varying concentration was added. Manganese dioxide (either freshly prepared &ggr;-manganese dioxide or activated manganese dioxide from Aldrich) was added and the reaction mixture was stirred at ambient temperature for 1.5 to 4 hours. The progress of the reaction was monitored by HPLC. The reaction mixture was filtered through a celite pad, washed with additional solvent or water, and neutralised with ammonium hydroxide. The product was extracted with methylene chloride (3×150 ml) and the combined extracts washed with water and dried over anhydrous sodium sulphate. The organic layer was then evaporated to yield codeinone.
In all the experiments the reaction was followed by HPLC and the retention time of the product was compared with that of the standard. In some cases the crude product was quantitated to obtain the purity. The HPLC analysis was done on a Shimadzu system. The column used was Phenomenex's Prodigy 5&mgr; ODS (3) 100° A, 250×4.6 mm. The method was isocratic. The mobile phase was: water (1450 ml)+acetonitrile (550 ml)+Et
3
N (2 ml)+1.73 g of 1-octanesulphonate, sodium salt+pH 3.5 (adjusted with 85% phosphoric acid). In the cases where the product was isolated, it was also characterised by comparing its
1
H NMR with that of the standard:
1
H NMR (CDCl
3
) &dgr;1.85-1.92(1H, m, 15
&agr;
), 2.05-2.15(1H, m, 16
&agr;
), 2.27-2.4(2H, m, 15
&bgr;
, 10
&agr;
), 2.45(3H, s, N—CH
3
), 2.58-2.62(1H, m, H
16&bgr;
), 3.07-3.14(1H, d, H
10&bgr;
), 3.19-3.21(1H, d, H
9&agr;
), 3.39-3.44(1H, m, H
14
), 3.84(3H, s, OCH
3
), 4.70(1H, s, H
5&bgr;
), 6.05-6.11(1H, dd, H
8
), 6.59-6.70(3H, m, H
1
, H
2
, H
7
).
REFERENCES:
patent: 2654756 (1953-10-01), Homeyer et al.
patent: 4277604 (1981-07-01), Dauben et al.
patent: 408 870 (1925-01-01), None
Seki, Chemical and Pharmaceutical Bulletin, vol. 18, No. 4, Jan. 1, 1970, pp. 671-676 (XP002078242).
Knorr, Chem. Ber., vol. 36, (1903), p. 3070.
Johnson Matthey Public Limited Company
Pillsbury & Winthrop LLP
Rotman Alan L.
LandOfFree
Preparation of opiates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of opiates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of opiates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2487180